Status:
RECRUITING
MicroRNA as Markers in Testicular Cancer
Lead Sponsor:
Haukeland University Hospital
Collaborating Sponsors:
Karolinska University Hospital
Sahlgrenska University Hospital
Conditions:
Testicular Germ Cell Cancer
Seminoma
Eligibility:
MALE
18-70 years
Brief Summary
The main objective of this study is establish the performance of miR371 in management of testicular cancer
Detailed Description
The main objective of the study is to asses the sensitivity and specificity of microRNA-371a-5p (miR371) in detection of viable testicular germ tumour cells. To assess the utility of miR371 at orchiec...
Eligibility Criteria
Inclusion
- Patients with suspected testicular cancer, referred to orchiectomy.
- Patients diagnosed with testicular germ cell cancer.
- Age 18-70 years of age.
- Must be able receive information and to consent.
Exclusion
- Other prior or concomitant malignancy (other than testicular cancer).
- Other diseases or conditions that hinder the ability to receive information and to participate in follow-up procedures.
Key Trial Info
Start Date :
December 31 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT04914026
Start Date
December 31 2016
End Date
December 31 2026
Last Update
August 8 2022
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Haukeland University Hospital
Bergen, Norway, 5021
2
Haugesund Hospital
Haugesund, Norway, 5528
3
Oslo University Hospital
Oslo, Norway, 0379
4
University Hospital of North Norway
Tromsø, Norway, 9038